Fiera Capital (Canada)
ALDR

Fiera Capital (Canada)’s Alder Biopharmaceuticals ALDR Stock Holding History

Fiera Capital (Canada)’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-145,658
Closed -$1.67M – 725
2017
Q2 		$1.67M Sell
145,658
-16,418
-10% -$304K 0.01% 401
2017
Q1 		$3.37M Sell
162,076
-6,551
-4% -$145K 0.02% 336
2016
Q4 		$3.51M Sell
168,627
-28,082
-14% -$730K 0.02% 384
2016
Q3 		$6.45M Sell
196,709
-3,653
-2% -$111K 0.04% 283
2016
Q2 		$5M Buy
+200,362
New +$5.42M 0.03% 319

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Fiera Capital (Canada)'s ALDR Position: Q3 2017 in Review

Fiera Capital (Canada) sold out of Alder Biopharmaceuticals (ALDR) in Q3 2017, closing a stake of 145,658 shares — an estimated $1.67M sold.

Fiera Capital (Canada) first reported a position in ALDR in Q2 2016 and held it in 5 quarters. The position peaked at $6.45M in Q3 2016. 132 funds tracked by Wall St. Rank hold ALDR as of Q3 2017.

  • Fiera Capital (Canada) reported no remaining Alder Biopharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Fiera Capital (Canada) sold 145,658 Alder Biopharmaceuticals shares in Q3 2017, an estimated $1.67M.
  • Fiera Capital (Canada) first reported a position in Alder Biopharmaceuticals in Q2 2016 and held it in 5 quarters.
  • Fiera Capital (Canada)'s Alder Biopharmaceuticals position peaked at $6.45M in Q3 2016.
  • 132 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2017, filed 13 Nov 2017.